论文部分内容阅读
目的对肺癌脑转移患者接受放疗治疗进行临床观察分析,研究放疗方法的治疗效果。方法对本院2007年4月-2008年4月肺癌脑转移患者100例,根据患者自愿选择治疗方式的情况将其分成两组,分别给予不同方法治疗进行回顾分析。将其中42例临床治疗时选择单纯接受放射治疗的患者设为对照组;另一组58例患者设为研究组,临床在对其进行放射治疗的同时再配合化疗方法进行联合治疗。根据两组患者临床接受不同方式治疗肺癌脑转移的疗效进行对比分析。结果研究组与对照组患者近期治疗效果观察比较差异无统计学意义(P>0.05),但是根据肺癌转移患者在一、两年内的生存率情况进行比较,研究组患者生存率要远高于对照组,差异有统计学意义(P<0.05)。结论通过临床对两组肺癌脑转移患者的治疗疗效进行分析可以得出,研究组患者生存期要明显高于对照组,使用放射治疗加化疗方法治疗肺癌脑转移患者可以明显延长患者的生存期,改善患者的生存环境以及质量,值得临床推广与应用。
Objective To evaluate the clinical effects of radiation therapy in patients with brain metastasis of lung cancer undergoing radiotherapy. Methods 100 patients with brain metastasis from lung cancer in our hospital from April 2007 to April 2008 were divided into two groups according to the patients’ voluntary choice of treatment. The patients were treated with different methods and analyzed retrospectively. Among them, 42 patients were treated with radiotherapy only as the control group. The other 58 patients were assigned as the research group. The patients were treated with radiotherapy and chemotherapy simultaneously. According to the two groups of patients clinically accepted different ways of treatment of brain metastases of lung cancer comparative analysis. Results There was no significant difference in short-term treatment effect between the study group and the control group (P> 0.05). However, the survival rate of patients in the study group was much higher than that of the control group Group, the difference was statistically significant (P <0.05). Conclusions Clinical analysis of the curative effect of two groups of patients with brain metastases of lung cancer shows that the survival time of the study group is significantly higher than that of the control group. The use of radiotherapy and chemotherapy in the treatment of patients with brain metastasis of lung cancer can significantly prolong the survival, Improve the living environment and quality of patients, it is worth clinical promotion and application.